Fengate taps Desautels advisor to chair board
Michael Boychuk (BCom'77, DPA'78) is the new Chair of the Advisory Board at Fengate Real Asset Investments, a board that he’s been on since 2014. Mr. Boychuk’s experience in capital markets is an asset at a time when Fengate is undergoing a period of huge growth. He served as Senior VP Treasurer at BCE until 2009, then President and CEO at Bimcor until 2015.
Samira Sakhia to present at investor conference
At the Bloom Burton & Co Healthcare Investor Conference this May, Knight Therapeutics’ president, Samira Sakhia (BCom’90, DPA’94, MBA’01) will be giving the Montreal-based specialty pharmaceutics company’s corporate update.
Imran Amed honoured with Vanguard Award
“I’m not looking at fashion through a Canadian lens, or even a Western lens, but a global lens,” says Imran Amed (BCom'97). Indeed, he doesn’t even look at it through the eyes of someone who grew up steeped in fashion. Mr. Amed started Business of Fashion as a personal blog while he was working as a management consultant with zero fashion training. Today, his London-based site is the go-to source for news-hungry glitterati.
Aldo founder passes the torch to his son
Aldo Bensadoun (BCom'64, LLD'12) is stepping down as chairman of the company that bears his name, as is CEO Patrik Frisk — but continuity won’t be a problem: Bensadoun’s son, David, is taking on the CEO job, starting this April.
Profound appoints Desautels alumna to its Board of Directors
In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom’90, MBA’01) to its Board of Directors. Ms. Sakhia is also a member of the Desautels International Advisory Board and serves as President of Knight Therapeutics.
Décollage Sainte-Ursule, direction Bombardier
Chaque fois qu'Alain Bellemare prend la route de Louiseville, il laisse derrière lui son titre de président et chef de la direction de Bombardier pour mieux redevenir le fils, le frère, le neveu et le cousin.
Ici, l'homme de 55 ans renoue avec ses racines... et se dit toujours prêt pour une partie de cartes. Le 500.
How ‘Mr. B’ Has Built Aldo Into a Global Shoe Powerhouse
On Tuesday, Nov. 29, Footwear News will host its 2016 Achievement Awards in New York, honoring the best and brightest in the industry, including Aldo Bensadoun, the winner of the Manolo Blahnik Lifetime Achievement Award. Read on to learn more Mr. B’s accomplishments.
People on the Move (October 2016 Update)
Samira Sakhia, president of Knight Therapeutics, has joined Crescita Therapeutics Inc.’s board of directors. Prior to her current role, she was the chief financial officer of Paladin Labs. She holds a Bachelor of Commerce degree in Finance and Accounting and a Masters of Business Administration in Strategy and Marketing from McGill University and is a Chartered Professional Accountant. Additionally, Dr.
Crescita Therapeutics Announces Changes to the Board of Directors
Crescita Therapeutics Inc. (Crescita or the Company), a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, today announced that Samira Sakhia, President of Knight Therapeutics, has joined its board of directors. Prior to her current role, Ms. Sakhia was the Chief Financial Officer of Paladin Labs. Ms.
People on the Move (August/September 2016)
A monthly roundup of ‘people on the move’ in Canada’s life science and biotech sectors.
Ferring Canada's donation to have lasting impact on Desautels Faculty of Management
Ferring Canada, a subsidiary of Ferring Pharmaceuticals, has contributed a $2-million dollar donation to the Faculties of Management and Medicine at McGill University, which will create new fellowships for graduate students working in the domains of health sciences and health management and leadership.
In conversation with Michel L. Pettigrew
Earlier today, Ferring Pharmaceuticals announced a $2 million donation to McGill to establish the Ferring Fellowships in Health Leadership in the Desautels Faculty of Management in the International Masters for Health Leadership Program (IMHL Program). The donation will also provide support for the renovation of the Desautels Faculty facilities.
A Knight is Reborn
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight.
Innover pour ne pas mourir
La Presse donne la parole aux grands dirigeants du Québec. Chaque vendredi, un patron répond à cinq questions posées par le chef d'entreprise interviewé la semaine précédente. Et ainsi de suite.
LE PARCOURS D'ALAIN BELLEMARE EN BREF
Âge : 55 ans
Études : Alain Bellemare est titulaire d'un baccalauréat en génie mécanique de l'Université de Sherbrooke et d'un MBA de l'Université McGill.
En poste depuis : février 2015
Meet the Man Who Bought NHL Tickets for an NL Soccer Team
A Montreal man who recently treated a young Newfoundland soccer team to a surprise NHL game, including a private audience with Montreal Canadiens' star P.K. Subban, says giving back is a big part of his personal philosophy.
